Recently, Valeant Pharmaceuticals were lambasted for their malicious business strategies in front of the Senate Special Committee on Aging at a congressional hearing. Their practice may be considered malevolent but it does not change the fact that numerous other pharmaceutical companies participate in the same practices to maximize their profits.
What Valeant executives fail to acknowledge is the fact that this company is hiking the price of critical drugs, making it unaffordable for people who require the drugs to purchase them.
Overall, the fact that pharmaceutical companies like Valeant are able to hike up their prices as such, it forces consumers to find affordable sources for their medication, such as from online pharmacies.